Publications by authors named "Pamela Becker"

Claim this Profile
L
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.
Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki, Sally Mokhtari, Diana Knobler, Pamela Becker

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment.
Tina Nguyen, Tanya Markary, Ni-Chun Tsai, Katrin Tiemann, Sally Mokhtari, Pamela Becker

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.
Hoda Pourhassan, Jose Tinajero, Huiyan Ma, Ryan Jackson, Raju Pillai, Pamela Becker

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Application of drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma.
Philip K Tan, Timothy J Martins, Pamela S Becker, Robert J Wechsler-Reya, John Ross Crawford

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3 (FLT3) inhibitors for both low-intensity and high-intensity regimens in FLT3-mutated acute myeloid leukemia.
Pamela S Becker

Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized dynamic risk assessment and treatment selection for multiple myeloma.
Carl Murie, Serdar Turkarslan, Anoop P Patel, David G Coffey, Pamela S Becker

Br J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.
Fei Fei, Milhan Telatar, Vanina Tomasian, Lisa Chang, Olga Danilova, Pamela S Becker

Oncotarget· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Ibrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, Caner Saygin, Marjorie Robbins, Pamela S Becker

Haematologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL.
Ibrahim Aldoss, Shanpeng Li, Jianying Zhang, Mary C Clark, Vaibhav Agrawal, Pamela S Becker

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.
Paul B Koller, Tamer Othman, Dongyun Yang, Sally Mokhtari, Yazeed Samara, Pamela S Becker

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis.
Diana T Samuels, Janny M Yao, Yazeed Samara, Dongyun Yang, Sally Mokhtari, Pamela Becker

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease.
Amanda Blackmon, Michelle Afkhami, Dongyun Yang, Sally Mokhtari, Yazeed Samara, Pamela Becker

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VenEx precisely predicts ven-aza response.
Pamela S Becker

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies.
Fei Fei, Milhan Telatar, Vanina Tomasian, Lisa Chang, Mariel Gust, Pamela S Becker

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.
Salman Otoukesh, Dongyun Yang, Sally Mokhtari, Hoda Pourhassan, Vaibhav Agrawal, Pamela Becker

Bone Marrow Transplant· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).
Hoda Pourhassan, Tina Nguyen, Dongyun Yang, Salman Otoukesh, Shukaib Arslan, Pamela Becker

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation.
Shukaib Arslan, Amrita Desai, Dongyun Yang, Sally Mokhtari, Katrin Tiemann, Pamela Becker

Transplant Cell Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation.
Amrita Desai, Yazeed Samara, Dongyun Yang, Brian Ball, Adam Braun, Pamela Becker

Leuk Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy.
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Pamela Becker

Leuk Lymphoma· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Noam E Kopmar, Megan Othus, Kim Quach, Allegra Rasmussen, Kelda Schonhoff, Pamela S Becker

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia.
Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J Martins, Brenda Loera, Pamela S Becker

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?
Geoffrey L Uy, Daniel J DeAngelo, Jay N Lozier, Dennis M Fisher, Brian A Jonas, Pamela S Becker

Blood Rev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized dynamic risk assessment for multiple myeloma.
Carl Murie, Serdar Turkarslan, Anoop Patel, David G Coffey, Pamela S Becker

medRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations.
Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, Junqiang Wang, Aleksandar Obradovic, Pamela S Becker

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening.
Pamela S Becker

Blood Cancer Discov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis